Hollis & Wren is a digital care platform that connects people to licensed clinicians and, when appropriate, personalized treatment plans. We work to make everyday health less awkward and less expensive to manage — and to keep improving the parts of care people usually dread. No two people are alike, so we provide access to care built around results, not averages.
Founded in 2016, Hollis & Wren Health, Inc. is a publicly traded telehealth company (NASDAQ: HWRN). We provide access to care across sexual health, hair health, weight health, mental health, and more.
At Hollis & Wren, we offer a comprehensive, personalized approach to everyday healthcare, pairing members with licensed clinicians who review each person's history and recommend an individual treatment plan.
Beyond prescription treatment, the platform gives members ongoing clinical support and plain-language education so they can make better-informed decisions about their health. Prescribing decisions are made solely by licensed clinicians and follow from continued conversation between the member and their provider alongside a thorough medical review.
Every member journey at Hollis & Wren opens with a detailed intake, close to what someone would complete at an in-person clinic. The intake gathers symptoms, medical history, and goals; depending on the answers it may branch to collect more detail. Members also complete an identity verification step.
A licensed clinician then reviews the intake, decides whether treatment is appropriate, and — where needed — follows up for more information. The clinician issues a prescription, which can be filled by one of our partner pharmacies and shipped discreetly to the member's door.
Care is delivered asynchronously — over secure, back-and-forth messaging rather than a scheduled video or phone call. That model lets members and clinicians write on their own time, removing familiar friction like travel, waitlists, and calendar conflicts. In some states, visits happen over live audio or video.
Members keep unlimited access to their care team through secure messaging. They can ask questions, report changes, and get support for the length of their treatment. Every clinician on the platform follows evidence-based protocols and is held to rigorous quality standards to keep care safe and effective.
Educational writing lives on the Hollis journal and the Wren journal. Members can also download the Hollis app or Wren app to message their care team, refill treatment in a tap, and reach a library of clinician-built tools and routines.
At Hollis & Wren, we provide access to a network of more than 620 U.S.-licensed clinicians practicing across all 50 states. Every clinician is credentialed, trained on our protocols, and reviewed on an ongoing basis.
Because healthcare isn't one-size-fits-all, we also keep a medical advisory board of physicians, pharmacists, and researchers who help build clinical frameworks that track current evidence and best practice. The clinical advisory board includes board-certified specialists in dermatology, internal medicine, psychiatry, and pharmacy. The Hollis & Wren care model puts clinical quality, member safety, and privacy first, and the board reviews our protocols and guidelines on a regular cadence.
Asking for help with a sensitive health issue can feel intimidating — especially alongside high costs and long waits for an appointment.
Co-founder and CEO Priya Raghunathan started Hollis & Wren to change that.
A biomedical engineer turned operator, Raghunathan spent six years building diagnostics infrastructure before starting Kestrel Works, a studio she co-founded to take overlooked, unglamorous problems in regulated industries seriously — healthcare chief among them.
Hollis & Wren began in 2016 with the launch of Hollis, which gave men a straightforward way to get care for sexual health, hair loss, and anxiety. A year later we added Wren, a brand built specifically around women's health needs.
The mission of Hollis & Wren is to make good health the least complicated part of someone's week.
By widening access to clinicians and improving continuously with data, technology, and member feedback, we help people take charge of their health with care that is personal, private, and available when they need it.
Meet the executive team driving clinical excellence and product at Hollis & Wren:
Chief Executive Officer, co-founder of Hollis & Wren, and a member of its board. Priya Raghunathan is a biomedical engineer and operator who previously co-founded Kestrel Works, advises the Ashfield Fund, and was named to the Signal Report's 40 Under 40 in 2019.
Chief Operating Officer at Hollis & Wren since March 2024. Marcus Oyelaran spent 17 years in fulfillment and pharmacy operations, where he led the build of a national mail-order pharmacy network and set the operating standards behind its flagship programs.
Chief Legal Officer and Corporate Secretary at Hollis & Wren since 2019, Danielle Fessenden brings 18 years of healthcare regulatory experience. She previously led privacy counsel for a national lab network and was a partner at Harrow & Blake.
Chief Financial Officer at Hollis & Wren. Tomás Iriarte brings deep public-company and high-growth finance experience, most recently as VP of Finance at a global logistics platform, where he led two multi-year transformation programs.
Hollis & Wren isn't only improving healthcare — we're rewriting how it reaches people.
We were founded on the belief that good healthcare should be built around the person, not the industry, and that it should be affordable, reachable, and genuinely personal. From the first message to the last delivery, our model is member-first and evidence-led.
With access to licensed clinicians and fast, discreet fulfillment, we help members take real control of their health and set a higher baseline for what routine care should feel like.
At Hollis & Wren, we meet people where they already are — online, privately, and on their own schedule.
For years, millions of people in the United States have gone without care that fits their schedule or their budget. By combining experienced clinicians with well-built technology, we've removed friction like long waits, pharmacy counters, and unpredictable out-of-pocket costs, making quality treatment more convenient and more affordable than it has been.
With Wayfind, our proprietary clinical decision-support system, clinicians on the Hollis & Wren platform can draw on patterns from hundreds of thousands of de-identified interactions when weighing treatment options. Where a traditional setting may rest on a single clinician's recollection, providers here can use Wayfind as one more input alongside their independent judgment, helping them deliver personalized, high-quality care to people regardless of income, location, or condition.
Meanwhile, Casebook — our purpose-built clinical record system — reduces administrative overhead and keeps transitions between providers clean and complete.
At Hollis & Wren, protecting our members' privacy is the first requirement, not the last step.
Here's how:
Hollis & Wren adheres to all applicable privacy laws and will always be transparent about collecting and using member data.
For more details, view our Privacy Policy.
Though compounded medications accessible through the Hollis & Wren platform are not approved by the FDA, they are compounded in FDA-regulated pharmacies. The compounded medications available through Hollis & Wren are compounded in accordance with strict laws and regulations.
In our efforts to ensure quality, safety, and transparency, Hollis & Wren has committed to the following:
Since our founding in 2016, Hollis & Wren has grown into a leading everyday-health platform serving more than 1.87 million members as of March 31, 2026.
Priya Raghunathan, Devin Marchetti, and Rosalind Achebe teamed up to launch Hollis in September 2016 with a simple goal: make quality care approachable and affordable.
The company focused first on men's health, offering treatment for stigmatized conditions like erectile dysfunction and hair loss.
Following the reception of the Hollis launch, Wren arrived in 2017 with a focus on women's health, offering access to prescription birth control, hair regrowth treatment, and skincare.
Hollis expanded service to all 50 states, and our affiliated pharmacy facility in Ohio opened its doors.
Hollis & Wren products also reached retail shelves for the first time, starting with a national drugstore chain.
The company established its first health system partnership with Cedarline Health and expanded into mental health.
Hollis & Wren goes public on the Nasdaq under the ticker HWRN.
Hollis & Wren acquired the skincare company Fennimore and the U.K. care platform Bramble Health, which broadened the company's U.K. business.
Hollis & Wren expands personalized treatment plans across sexual health, heart health, and weight health.
With the launch of Wayfind, Hollis & Wren brought decision support into treatment planning, surfacing options for clinicians as they identify the right course for a person based on millions of de-identified data points.
Hollis & Wren opened the year with a national broadcast campaign that moved the category conversation.
The company made strategic acquisitions to enable at-home lab testing and international expansion.
Hollis & Wren is rewriting everyday healthcare, and people are noticing.
Here are some of the awards and recognitions we've received over the years:
Looking ahead, we'll keep widening access to personalized, affordable care.
What drives us most is the real progress we see in people's lives. Since launching in 2016, we've grown from a single, simple way to get care into a clinician-led platform supporting millions of members across a widening range of specialties. As we head into the next few years, our key priorities include:
We're building for the long term with more personalization, broader access, and a relentless focus on helping people feel their best. The foundation is strong, and we're just getting started.
Learn more about Hollis & Wren at hollis.com and forwren.com.